|
Enhancing Treg Immune Reconstitution After Stem Cell Transplant
|
5R21CA149967-02
|
$311,709
|
$311,709
|
BOLLARD, CATHERINE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Guideline-based surveillance and treatment of hepatocellular carcinoma
|
5R01CA160738-02
|
$324,738
|
$324,738
|
Davila, Jessica
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$1,243
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$2,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$88,043
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pathophysiology of Post-Transplantation Cancer
|
5R01CA131145-04
|
$350,219
|
$350,219
|
Pal, Soumitro
|
CHILDREN'S HOSPITAL BOSTON
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-08
|
$325,549
|
$162,775
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Nonadherence: Undermining health outcomes in pediatric HSCT?
|
1R01CA157460-01A1
|
$543,062
|
$543,062
|
PAI, AHNA
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-02
|
$317,475
|
$317,475
|
PANG, QISHEN
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
|
CCNY/MSK Cancer Center Partnership, Training and Community Outreach
|
5U54CA132378-05
|
$1,663,704
|
$282,830
|
HUBBARD, KAREN
|
CITY COLLEGE OF NEW YORK
|
|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
2R01CA077544-11A1
|
$29,183
|
$29,183
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-07
|
$2,300,000
|
$575,000
|
Forman, Stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-29S1
|
$91,911
|
$4,596
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-29S2
|
$139,999
|
$7,000
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-29S3
|
$75,000
|
$3,750
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-29
|
$2,225,352
|
$111,268
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Interplay Between Cancer and Immune Cells on Targeted Therapy
|
7R01CA130817-06
|
$341,262
|
$170,631
|
Lee, Peter
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
|
5P01CA043904-21
|
$1,218,233
|
$365,470
|
RAUBITSCHEK, ANDREW
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Evaluating New Targets of CMV Cellular Immunity
|
5R01CA145207-07
|
$393,139
|
$393,139
|
Zaia, John
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Combination Therapy With 5-FU and PDT For The Treatment Of Post-Transplant Premal
|
5R21CA156227-02
|
$199,851
|
$199,851
|
MAYTIN, EDWARD
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Multi-Method Study of Cancer Patients' Medication Adherence After Allogeneic HSCT
|
1R03CA162980-01A1
|
$80,000
|
$80,000
|
Stadler, Gertraud
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
5P01CA078378-13
|
$1,974,463
|
$493,616
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-20
|
$278,781
|
$41,817
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Mechanisms of GVHD
|
5P01CA142106-09
|
$1,867,308
|
$1,867,308
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$223,292
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$1,131
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
$1,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Integrative Oncogenomics of Multiple Myeloma
|
5P01CA155258-02
|
$1,999,347
|
$179,941
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INSTITUTE
|
|
Novel Approaches to Stem Cell Transplantation
|
5P01CA047741-19
|
$1,778,779
|
$1,778,779
|
Chao, Nelson
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-38S1
|
$75,000
|
$5,250
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-38
|
$5,723,821
|
$400,667
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Inhibition of Cytochrome c-induced Caspase Activation
|
5R01CA102707-08
|
$263,055
|
$86,808
|
KORNBLUTH, SALLY
|
DUKE UNIVERSITY
|
|
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
|
5R01CA136934-04
|
$313,989
|
$313,989
|
YANG, YIPING
|
DUKE UNIVERSITY
|
|
Adult Leukemia Research Center
|
2P01CA018029-37A1
|
$4,225,448
|
$2,197,233
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted Radiotherapy with 90Y-BC8 Monclonal Antibody, Fludarabine and TBI Follow
|
5R21CA155911-02
|
$340,471
|
$340,471
|
BENSINGER, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediatric Oncology Research Training Program
|
2T32CA009351-34
|
$235,116
|
$94,046
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-14
|
$550,042
|
$275,021
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-02
|
$170,100
|
$170,100
|
Bleakley, Marie
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
2R01CA054498-21A1
|
$714,157
|
$71,416
|
BRESLOW, NORMAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
|
5K07CA151775-02
|
$151,059
|
$151,059
|
Chow, Eric
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-38S1
|
$116,988
|
$10,529
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-38S2
|
$139,999
|
$12,600
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-38S3
|
$74,876
|
$6,739
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-38S4
|
$50,000
|
$4,500
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-38S5
|
$211,800
|
$19,062
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-38
|
$11,373,047
|
$1,023,574
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Radioimmunotherapy for Multiple Myeloma
|
5K08CA151682-03
|
$169,560
|
$42,390
|
Green, Damian
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot
|
5R01CA138720-03
|
$354,244
|
$354,244
|
PAGEL, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Significance of MHC Haplotypes in HCT
|
5R01CA100019-10
|
$334,184
|
$334,184
|
Petersdorf, Effie
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Organ Transplantation Research for this search: $59,439,170
|